Increased PTHRP production by a tyrosine kinase oncogene, Tpr-Met: Role of the Ras signaling pathway

American Journal of Physiology - Endocrinology and Metabolism

Volumn 271, Issue 2 34-2, 1996, Pages

  Aklilu, F ^b   Park, M ^b   Goltzman, D ^b   Rabbani, S A ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b NONE

Author keywords

lovastatin; parathyroid hormone related peptide; phosphatidylinositol 3 kinase; wortmannin

Indexed keywords

DACTINOMYCIN; MESSENGER RNA; MEVINOLIN; ONCOPROTEIN; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATIDYLINOSITOL KINASE; PROTEIN P21; PROTEIN TYROSINE KINASE; RAS PROTEIN; WORTMANNIN;

ANIMAL CELL; ARTICLE; CELL GROWTH; CONTROLLED STUDY; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; ISOPRENYLATION; NONHUMAN; NORTHERN BLOTTING; ONCOGENE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION;

EID: 0029771629     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1996.271.2.e277     Document Type: Article

References (30)

1. Bottaro, D. P., J. S. Rubin, D. L. Faletto, A. M. Chan, T. E. Kmiecik, G. F. Vande Woude, and S. A. Aaronson. Identification of the hepatocyte growth factor receptor as the c-Met proto-oncogene product. Science Wash. DC 251: 802-804, 1991.
2. Burton, P. B., C. Moniz, and D. Knight. Parathyroid hormone related peptide can function as an autocrine growth factor in human renal cell carcinoma. Biochem. Biophys. Res. Commun. 167: 1134-1138, 1990.
3. Cochran, B. H. Regulation of immediate early gene expression. NIDA Res. Monogr. 125: 3-24, 1993.
4. Fenton, R. G., H. F. Kung, D. L. Longo, and M. R. Smith. Regulation of intracellular actin polymerization by prenylated cellular proteins. J. Cell Biol. 117: 347-356, 1992.
5. Fixman, E. D., M. A. Naujokas, G. A. Rodrigues, M. F. Moran, and M. Park. Efficient cell transformation by the Tpr-Met oncoprotein is independent upon tyrosine 489 in the carboxy-terminus. Oncogene 10: 1-13, 1995.
6. Haq, M., R. Kremer, D. Goltzman, and S. A. Rabbani. A vitamin D analogue (EB1089) inhibits parathyroid hormone related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo. J. Clin. Invest. 91: 2416-2422, 1993.
7. Heath, J. K., J. Southby, S. Fukumoto, L. M. O'Keefe, T. J. Martin, and M. T. Gillespie. Epidermal growth factor stimulated parathyroid hormone-related protein expression involves increase gene transcription and mRNA stability. Biochem. J. 307: 159-167, 1995.
8. Henderson, J., C. Shustik, R. Kremer, S. A. Rabbani, G. N. Hendy, and D. Goltzman. Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism. J. Bone Miner. Res. 5: 105-113, 1989.
9. Henderson, J. E., M. Sebag, J. S. Rhim, D. Goltzman, and R. Kremer. Dysregulation of parathyroid hormone-like peptide expression and secretion in a keratinocyte model of tumor progression. Cancer Res. 51: 6521-6528, 1991.
10. Jüppner, H., A. Abou-Samra, M. Freeman, X. F. Kong, E. Schipani, J. Richards, L. F. Kolakowski, J. Hock, J. T. Potts, H. M. Kronenberg, and G. V. Segre. A G protein linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science Wash. DC 254: 1024-1026, 1991.
11. Karaplis, A. C., T. Yasuda, G. N. Hendy, D. Goltzman, and D. G. Banville. Gene-encoding parathyroid hormone-like peptide: nucleotide sequences of the rat gene and comparison with the human. Mol. Endocrinol. 4: 441-446, 1990.
12. Li, X., and D. J. Drucker. Parathyroid hormone-related peptide is a downstream target for ras and src activation. J. Biol. Chem. 269: 6263-6266, 1994.
13. Li, X., and D. J. Drucker. Growth factor-like properties of parathyroid hormone-related peptide in transfected rodent cell lines. Cancer Res. 53: 2980-2986, 1994.
14. Liu, B., D. Goltzman, and S. A. Rabbani. Regulation of parathyroid hormone related peptide production in vitro by the rat hypercalcemic Leydig cell tumor H-500. Endocrinology 132: 1658-1664, 1993.
15. Moseley, J. M., M. Kubota, H. D. Diefenbach-Jagger, R. E. H. Wettenhall, B. E. Kemp, L. J. Suva, C. P. Rodda, P. R. Ebeling, P. J. Hudson, J. D. Zajac, and T. J. Martin. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc. Natl. Acad. Sci. USA 84: 5048-5052, 1987.
16. Park, M., M. Dean, C. S. Cooper, M. Schmidt, S. T. O'Brien, D. G. Blair, and G. Vande Woude. Mechanism of met oncogene activation. Cell 45: 895-904, 1986.
17. 16a. Pawson, T. SH2 and SH3 domains in signal transduction. Adv. Cancer Res. 64: 87-110, 1994.
18. Powis, G., R. Bonjouklian, M. M. Berggren, A. Gallegos, R. Abraham, C. Ashendel, L. Zalkow, W. F. Matter, J. Dodge, G. Grindey, and C. J. Vlahos. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54: 2419-2423, 1994.
19. Rabbani, S. A., J. Mitchell, D. R. Roy, G. N. Hendy, and D. Goltzman. Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy. Endocrinology 123: 2709-2716, 1988.
20. Rabbani, S. A., J. Mitchell, D. R. Roy, R. Kremer, H. P. J. Bennett, and D. Goltzman. Purification of peptides with parathyroid hormone-like bioactivity from human and rat malignancies associated with hypercalcemia. Endocrinology 118: 1200-1210, 1986.
21. Reusch, J. E., P. Bhuripanyo, K. Carel, J. W. Leitner, P. Hsieh, D. DePaolo, and B. Draznin. Differential requirement for p21ras activation in the metabolic signaling by insulin. J. Biol. Chem. 270: 2036-2040, 1995.
22. Rodrigues, G. A., and M. Park. Dimerization mediated through a leucine zipper activates the oncogenic potential of the met receptor tyrosine kinase. Mol. Cell. Biol. 13: 6711-6722, 1993.
23. Sebag, M., J. Henderson, D. Goltzman, and R. Kremer. Regulation of parathyroid hormone-related peptide production in normal human mammary epithelial cells in vitro. Am. J. Physiol. 267 (Cell Physiol. 36): C723-C730, 1994.
24. Shaw, G., and R. Kamen. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667, 1986.
25. Sinenskv, M., L. A. Beck, S. Leonard, and R. Evans. Differential inhibitory effects of lovastatin on protein isoprenylation and sterol synthesis. J. Biol. Chem. 265: 19937-19941, 1990.
26. Stewart, A. F., T. Wu, D. Goumas, W. J. Burtis, and A. E. Broadus. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem. Biophys. Res. Commun. 146: 672-678, 1987.
27. Torczynski, R., A. P. Bollon, and M. Fuke. The complete nucleotide sequence of the rat 18s ribosomal RNA gene and comparison with the respective yeast and frog genes. Nucleic Acids Res. 11: 4879-4890, 1983.
28. Yamamoto-Honda, R., T. Kazuyuki, Y. Kaburagi, U. Kohjiro, S. Asai, M. Yachi, M. Shirouzu, J. Yodoi, Y. Akanuma, S. Yokoyama, Y. Yazaki, and T. Kadowaki. Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I. J. Biol. Chem. 270: 2729-2734, 1995.
29. Yasuda, T., D. Banville, G. N. Hendy, and D. Goltzman. Characterization of the human parathyroid hormone-like peptide gene. J. Biol. Chem. 264: 7720-7725, 1989.
30. Yasuda, T., D. Banville, S. A. Rabbani, G. N. Hendy, and D. Goltzman. Rat parathyroid hormone-like peptide: comparison with the human homologue and expression in malignant and normal tissue. Mol. Endocrinol. 3: 518-525, 1989.